Corticotropin-releasing hormone and the blood-brain-barrier

10.2741/2174 ◽  
2007 ◽  
Vol 12 (1) ◽  
pp. 1615 ◽  
Author(s):  
Theoharis, C. Theoharides
Endocrinology ◽  
2009 ◽  
Vol 151 (3) ◽  
pp. 1221-1227 ◽  
Author(s):  
Hung Hsuchou ◽  
Abba J. Kastin ◽  
Xiaojun Wu ◽  
Hong Tu ◽  
Weihong Pan

In this study we tested the hypothesis that receptor-mediated transport of urocortin across the blood-brain barrier (BBB) undergoes developmental changes. Urocortin is a peptide produced by both selective brain regions and peripheral organs, and it is involved in feeding, memory, mood, cardiovascular functions, and immune regulation. In BBB studies with multiple-time regression analysis, we found that neonatal mice had a significant influx of 125I-urocortin. By contrast, adult mice did not transport urocortin across the BBB. Quantitative RT-PCR showed that corticotropin-releasing hormone receptor (CRHR)-1 was developmentally regulated in enriched cerebral microvessels as well as hypothalamus, being significantly higher in neonatal than adult mice. This change was less dramatic in agouti viable yellow mice, a strain that develops adult-onset obesity. The level of expression of CRHR1 mRNA was 33-fold higher in the microvessels than in hypothalamic homogenates. The mRNA for CRHR2 was less abundant in both regions and less prone to changes with development or the agouti viable yellow mutation. Supported by previous findings of receptor-mediated endocytosis of urocortin, these results suggest that permeation of urocortin across the BBB is dependent on the level of CRHR1 expression in cerebral microvessels. These novel findings of differential regulation of CRH receptor subtypes help elucidate developmental processes in the brain, particularly for the urocortin system.


1980 ◽  
Vol 32 (1) ◽  
pp. 722-724 ◽  
Author(s):  
TH. J. POSTMES ◽  
M. HUKKELHOVEN ◽  
A. E. J. M. BOGAARD ◽  
S. G. HALDERS ◽  
J. COENEGRACHT

1988 ◽  
Vol 51 (1) ◽  
pp. 252-257 ◽  
Author(s):  
Berislav V. Zloković ◽  
Milo N. Lipovac ◽  
David J. Begley ◽  
Hugh Davson ◽  
Ljubiša Rakić

1983 ◽  
Vol 36 (2) ◽  
pp. 102-104 ◽  
Author(s):  
Christian Verheugen ◽  
Larry R. Laufer ◽  
John L. DeFazio ◽  
William B. Pardridge ◽  
John K.H. Lu ◽  
...  

1997 ◽  
Vol 273 (6) ◽  
pp. E1083-E1089 ◽  
Author(s):  
J. Martin Martins ◽  
William A. Banks ◽  
Abba J. Kastin

The blood-brain barrier (BBB) regulates the passage of substances between the brain and the periphery. It has not been shown that the secretion from the brain of a small amount of a substance can directly affect the periphery by transport across the BBB. We found that central injection of radioactively labeled corticotropin-releasing hormone (CRH) resulted in the accumulation of intact CRH in the spleen. CRH also increased splenic β-endorphin, an effect not blocked by pretreatment with dexamethasone. Inhibition of the secretion of CRH from the brain by colchicine resulted in decreased accumulation of CRH in the spleen and also decreased splenic β-endorphin. Similar findings occurred in the pituitary gland. The results show that the passage of labeled CRH from the brain can directly affect a peripheral organ, thus emphasizing the regulatory function of the BBB.


Sign in / Sign up

Export Citation Format

Share Document